B cells undergo a complex series of maturation and selection steps in the bone marrow and spleen during differentiation into mature immune effector cells. The tumor necrosis factor (TNF) family member B cell activating factor of the TNF family (BAFF) (BLyS/TALL-1) plays an important role in B cell homeostasis. BAFF and its close homologue a proliferation-inducing ligand (APRIL) have both been shown to interact with at least two receptors, B cell maturation antigen (BCMA) and transmembrane activator and cyclophilin ligand interactor (TACI), however their relative contribution in transducing BAFF signals in vivo remains unclear. To functionally inactivate both BAFF and APRIL, mice transgenic for a soluble form of TACI were generated. They display a developmental block of B cell maturation in the periphery, leading to a severe depletion of marginal zone and follicular B2 B cells, but not of peritoneal B1 B cells. In contrast, mice transgenic for a soluble form of BCMA, which binds APRIL, have no detectable B cell phenotype. This demonstrates a crucial role for BAFF in B cell maturation and strongly suggests that it signals via a BCMA-independent pathway and in an APRIL-dispensable way.
Skip Nav Destination
Article navigation
3 December 2001
Brief Definitive Report|
December 03 2001
Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen
Pascal Schneider,
Pascal Schneider
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Search for other works by this author on:
Hisakazu Takatsuka,
Hisakazu Takatsuka
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Search for other works by this author on:
Anne Wilson,
Anne Wilson
3Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland
Search for other works by this author on:
Fabienne Mackay,
Fabienne Mackay
4Garvan Institute of Medical Research, St. Vincent Hospital, Darlinghurst NSW 2010, Sydney, Australia
Search for other works by this author on:
Aubry Tardivel,
Aubry Tardivel
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Search for other works by this author on:
Susanne Lens,
Susanne Lens
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Search for other works by this author on:
Teresa G. Cachero,
Teresa G. Cachero
5Biogen, Department of Protein Chemistry, Cambridge, MA 02142
Search for other works by this author on:
Daniela Finke,
Daniela Finke
2Swiss Institute for Experimental Cancer Research, Lausanne Branch, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland
Search for other works by this author on:
Friedrich Beermann,
Friedrich Beermann
2Swiss Institute for Experimental Cancer Research, Lausanne Branch, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland
Search for other works by this author on:
Jürg Tschopp
Jürg Tschopp
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Search for other works by this author on:
Pascal Schneider
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Hisakazu Takatsuka
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Anne Wilson
3Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland
Fabienne Mackay
4Garvan Institute of Medical Research, St. Vincent Hospital, Darlinghurst NSW 2010, Sydney, Australia
Aubry Tardivel
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Susanne Lens
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Teresa G. Cachero
5Biogen, Department of Protein Chemistry, Cambridge, MA 02142
Daniela Finke
2Swiss Institute for Experimental Cancer Research, Lausanne Branch, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland
Friedrich Beermann
2Swiss Institute for Experimental Cancer Research, Lausanne Branch, University of Lausanne, Boveresses 155, CH-1066 Epalinges, Switzerland
Jürg Tschopp
1Institute of Biochemistry, BIL Biomedical Research Center, University of Lausanne, the
Address correspondence to Jürg Tschopp, Institute of Biochemistry, University of Lausanne, Ch. des Boveresses 155, CH-1066 Epalinges, Switzerland. Phone: 41-21-692-5738/5706; Fax: 41-21-692-5705; E-mail: [email protected]
P. Schneider and H. Takatsuka contributed equally to this paper.
Received:
July 30 2001
Revision Received:
September 24 2001
Accepted:
October 04 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2001
J Exp Med (2001) 194 (11): 1691–1698.
Article history
Received:
July 30 2001
Revision Received:
September 24 2001
Accepted:
October 04 2001
Citation
Pascal Schneider, Hisakazu Takatsuka, Anne Wilson, Fabienne Mackay, Aubry Tardivel, Susanne Lens, Teresa G. Cachero, Daniela Finke, Friedrich Beermann, Jürg Tschopp; Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen . J Exp Med 3 December 2001; 194 (11): 1691–1698. doi: https://doi.org/10.1084/jem.194.11.1691
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement